Reaching new heights in biomarker solutions Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
In Safe Hands Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Setting New Standards Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Ahead of the Pack Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Leading from the Front Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications

Biomarker Assays

Biomarker Assays
Rapid development of TMT-SRM mass spectrometry assays for biomarker validation and routine measurement Learn More

Biomarker Services

Biomarker Services
Unique peptidomic and proteomic workflows using TMT with LTQ Orbitrap for maximum coverage in discovery and validation Learn More

Proprietary Biomarkers

Proprietary Biomarkers
Biomarkers for Alzheimer's disease, stroke, cancer and other indications Learn More

What's new

Proteome Sciences to receive the Science & Technology Award for TMT at the upcoming HUPO World Congress

Learn More

News

1 of 3
02 Oct, 2014 / Director Dealing The Board of Proteome announces that Geoff Ellis, Finance Director, has today been granted options over 300,000 ordinary shares of 1p each under the Company’s 2011 Long Term Incentive Plan (“LTIP”).
Read More
26 Sep, 2014 / Excellent Toxicity Results for PS110 and PS278-05 in Alzheimer’s disease Proteome Sciences is very pleased to announce that the two external in vitro toxicity safety tests (Ames and Cyp) have shown no adverse data for either of the two lead compounds, PS110 and PS278-05 for its CK1d programme
Read More

Events

02 Nov, 2014 / NCRI Cancer Conference 2014 Join us as for a Collaboration between clinicians and researchers at the 10th Annual NCRI Cancer…

Read More
18 Nov, 2014 / 26th EORTC-NCI-AACR Symposium the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will take place in Barcelona…

Read More